In its third year, the Scripps Research Biotech Research Summit aims to foster strategic partnerships between academia and industry and accelerate innovation across the biotech spectrum.
Under the guidance of the Strategic Investment Committee, this year’s program includes engaging sessions focused on empowering scientific talent and forging meaningful connections. This event provides an exclusive opportunity to engage with world-class scientists who are pioneering exciting early-stage innovations.
We are thrilled to announce our 2026 featured keynote conversation with Thomas Kurian, CEO, Google Cloud and Jorge Reis-Filho, MD, PhD, FRCPath, Former Chief of AI for Science Innovation and Chief AI and Data Scientist for Oncology R&D at AstraZeneca.
See the full speaker lineup on the speakers page.
What You’ll Experience
Faculty Spotlights – Presentations highlighting groundbreaking new technologies from Scripps faculty.
AI-Enabled Discovery – The latest in functional genomics, molecular design, and structural biology.
Translational Innovation – Exclusive updates on clinical-stage programs, digital clinical trials, and the translational capabilities of Scripps and Calibr-Skaggs.
Industry & Investor Perspectives – AI partnerships, commercialization strategies, and emerging opportunities across biotech and pharma, highlighting a new Scripps spin-out.
Interactive Networking – Lean-In Sessions (small-group discussions designed to encourage candid conversations and new collaborations), investor engagement, and networking with scientists, founders, and industry leaders across the biotech ecosystem.
Interested in hosting a Lean-In Session?
If you’re an investor or industry leader interested in hosting a Lean-In table, please contact biotechsummit@scripps.edu.
THANK YOU TO OUR 2026 SPONSORS
Interested in sponsorship? View the sponsorship prospectus and submit an interest form to discuss options with our team.
ABOUT SCRIPPS RESEARCH
Founded 100 years ago, Scripps Research is globally renowned and ranked among the world’s top most innovative institutes. We empower our scientists to pursue high-risk, high-reward ideas that transform our understanding of the world and lead to new technologies that shape our future.
In addition to pioneering technologies in chemical synthesis, synthetic biology and biotechnology, our scientists have contributed to major advances in understanding the adaptive and innate immune systems, sensory neurobiology and cellular signaling. We’re proud to have played a pivotal role in the development of 17 FDA-approved drugs and vaccines.
